These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 8684125)
1. Combined loss of BRCA1/BRCA2 in grade 3 breast carcinomas. Kelsell DP; Spurr NK; Barnes DM; Gusterson B; Bishop DT Lancet; 1996 Jun; 347(9014):1554-5. PubMed ID: 8684125 [No Abstract] [Full Text] [Related]
2. A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2. Ramus SJ; Friedman LS; Gayther SA; Ponder BA; Bobrow L; van der Looji M; Papp J; Olah E Nat Genet; 1997 Jan; 15(1):14-5. PubMed ID: 8988162 [No Abstract] [Full Text] [Related]
3. Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer. Beckmann MW; Picard F; An HX; van Roeyen CR; Dominik SI; Mosny DS; Schnürch HG; Bender HG; Niederacher D Br J Cancer; 1996 May; 73(10):1220-6. PubMed ID: 8630282 [TBL] [Abstract][Full Text] [Related]
4. The genetics of inherited breast cancer. Gayther SA; Pharoah PD; Ponder BA J Mammary Gland Biol Neoplasia; 1998 Oct; 3(4):365-76. PubMed ID: 10819531 [TBL] [Abstract][Full Text] [Related]
5. Allelic imbalance and microsatellite instability in BRCA1 associated breast and ovarian tumors. van der Looij M; Papp J; Sztán M; Pulay T; Elfadil I; Besznyak I; Tóth J; Devilee P; Oláh E Int J Oncol; 2001 Apr; 18(4):775-80. PubMed ID: 11251173 [TBL] [Abstract][Full Text] [Related]
6. Breast cancer genes. Further enigmatic variations. Davies K Nature; 1995 Dec 21-28; 378(6559):762-3. PubMed ID: 8524409 [No Abstract] [Full Text] [Related]
7. Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Marcus JN; Watson P; Page DL; Narod SA; Lenoir GM; Tonin P; Linder-Stephenson L; Salerno G; Conway TA; Lynch HT Cancer; 1996 Feb; 77(4):697-709. PubMed ID: 8616762 [TBL] [Abstract][Full Text] [Related]
8. Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset). Lo YL; Yu JC; Huang CS; Tseng SL; Chang TM; Chang KJ; Wu CW; Shen CY Int J Cancer; 1998 Dec; 79(6):580-7. PubMed ID: 9842965 [TBL] [Abstract][Full Text] [Related]
9. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium. Lancet; 1997 May; 349(9064):1505-10. PubMed ID: 9167459 [TBL] [Abstract][Full Text] [Related]
11. [A genetic test for breast cancer: curse or blessing?]. Sauer H Fortschr Med; 1995 Feb; 113(4):9-10. PubMed ID: 7713472 [No Abstract] [Full Text] [Related]
12. Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma. Rio PG; Pernin D; Bay JO; Albuisson E; Kwiatkowski F; De Latour M; Bernard-Gallon DJ; Bignon YJ Int J Oncol; 1998 Oct; 13(4):849-53. PubMed ID: 9735416 [TBL] [Abstract][Full Text] [Related]
13. Double heterozygosity for mutations in the BRCA1 and BRCA2 genes in a breast cancer patient. Tsongalis GJ; Linfert DR; Johnson RC; Ackroyd R; Berman MM; Ricci A Arch Pathol Lab Med; 1998 Jun; 122(6):548-50. PubMed ID: 9625424 [TBL] [Abstract][Full Text] [Related]
14. A somatic truncating mutation in BRCA2 in a sporadic breast tumor. Weber BH; Brohm M; Stec I; Backe J; Caffier H Am J Hum Genet; 1996 Oct; 59(4):962-4. PubMed ID: 8808615 [No Abstract] [Full Text] [Related]
15. Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer. Tseng SL; Yu IC; Yue CT; Chang SF; Chang TM; Wu CW; Shen CY Genes Chromosomes Cancer; 1997 Dec; 20(4):377-82. PubMed ID: 9408754 [TBL] [Abstract][Full Text] [Related]
16. BRCA1 mutations in primary breast and ovarian carcinomas. Futreal PA; Liu Q; Shattuck-Eidens D; Cochran C; Harshman K; Tavtigian S; Bennett LM; Haugen-Strano A; Swensen J; Miki Y Science; 1994 Oct; 266(5182):120-2. PubMed ID: 7939630 [TBL] [Abstract][Full Text] [Related]
17. Allelic imbalance in the region of the BRCA1 gene in ductal carcinoma in situ of the breast. Munn KE; Walker RA; Menasce L; Varley JM Br J Cancer; 1996 Mar; 73(5):636-9. PubMed ID: 8605099 [TBL] [Abstract][Full Text] [Related]
18. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Tirkkonen M; Johannsson O; Agnarsson BA; Olsson H; Ingvarsson S; Karhu R; Tanner M; Isola J; Barkardottir RB; Borg A; Kallioniemi OP Cancer Res; 1997 Apr; 57(7):1222-7. PubMed ID: 9102202 [TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity (LOH) at p53 is correlated with LOH at BRCA1 and BRCA2 in various human malignant tumors. Tong D; Kucera E; Schuster E; Schmutzler RK; Swoboda H; Reinthaller A; Leodolter S; Zeillinger R Int J Cancer; 2000 Oct; 88(2):319-22. PubMed ID: 11004687 [No Abstract] [Full Text] [Related] [Next] [New Search]